SCHEMBL24285948

SCHEMBL24285948

Nc1nc2ccc(-c3c[nH]c4ccc(Cl)cc34)cn2c1C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K14 Q99558 2/20 0.43
▸ DYRK1A Q13627 1/20 0.39
▸ ALOX5 P09917 1/20 0.37
▸ ATP4A P20648 3/20 0.37
▸ ATP4B P51164 3/20 0.37
▸ HTR1A P08908 1/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ PIM1 P11309 3/20 0.36
▸ PIM3 Q86V86 3/20 0.36
▸ PIM2 Q9P1W9 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24285949 0.76 LRRK2 (0.39) MAP3K14DYRK1AATP4AATP4BF7
SCHEMBL24285978 0.75 CAMKK2 (0.47) DYRK1APIM1KMT2A
SCHEMBL24286014 0.75 USP7 (0.32) ALDH1A1
SCHEMBL24285859 0.73 CA12 (0.45) DYRK1AMAPT
SCHEMBL24285941 0.72 TDO2 (0.33) ALDH1A1CYP3A4
SCHEMBL24286245 0.71 MET (0.44) PIM1PIM3ALDH1A1SMN1; SMN2
SCHEMBL24285966 0.70 MAP4K1 (0.34) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24285992 0.69 BRAF (0.33) PIM1PIM3ALDH1A1CYP1A2CYP3A4
SCHEMBL17982251 0.69 GPR84 (0.55) MAP3K14DYRK1AALOX5HTR1AHTR7
SCHEMBL24286655 0.68 MAPT (0.47) ALOX5MAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11744824-B2 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds 1ST Biotherapeutics, Inc. (KR) 2023-09-05 — — US disclosed
US-20220087985-A1 2-AMINO-3-CARBONYL IMIDAZOPYRIDINE AND PYRAZOLOPYRIDINE COMPOUNDS 1ST Biotherapeutics, Inc. (KR) 2022-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11744824-B2 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds NLRP3, NLRP1, KCNJ2 MAP3K14 201/4885DYRK1A 1877/4885ALOX5 2068/4885
US-20220087985-A1 2-AMINO-3-CARBONYL IMIDAZOPYRIDINE AND PYRAZOLOPYRIDINE COMPOUNDS NLRP3, NLRP1, KCNJ2 MAP3K14 201/4885DYRK1A 1877/4885ALOX5 2068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback